{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:50Z","timestamp":1793060030568,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.cyto.2008.10.007","type":"journal-article","created":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T12:15:22Z","timestamp":1227010522000},"page":"373-376","source":"Crossref","is-referenced-by-count":116,"title":["Interleukin-6 in neuro-Beh\u00e7et\u2019s disease: Association with disease subsets and long-term outcome"],"prefix":"10.1016","volume":"44","author":[{"given":"G\u00fcl\u015fen","family":"Akman-Demir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"T\u00fcz\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema","family":"\u0130\u00e7\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil\u00fcfer","family":"Ye\u015filot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel P.","family":"Yent\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"K\u00fcrt\u00fcnc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melike","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcher","family":"Saruhan-Direskeneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2008.10.007_bib1","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Beh\u00e7et\u2019s disease: evaluation of 200 patients. The neuro-Beh\u00e7et Study Group","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.cyto.2008.10.007_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/clin.1996.4268","article-title":"Cerebrospinal fluid interleukin-6 in progressive neuro-Beh\u00e7et\u2019s syndrome","volume":"82","author":"Hirohata","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.cyto.2008.10.007_bib3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00296-007-0367-9","article-title":"Pro-inflammatory cellular immune response in Beh\u00e7et\u2019s disease","volume":"27","author":"Kulaber","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cyto.2008.10.007_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780290310","article-title":"Analysis of interleukin-2 activity in patients with Beh\u00e7et\u2019s disease. Ability of T cells to produce and respond to interleukin-2","volume":"29","author":"Sakane","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2008.10.007_bib5","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1346-8138.2003.tb00442.x","article-title":"Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Beh\u00e7et\u2019s disease","volume":"30","author":"Aridogan","year":"2003","journal-title":"J Dermatol"},{"key":"10.1016\/j.cyto.2008.10.007_bib6","first-page":"599","article-title":"Anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with neuro-Beh\u00e7et\u2019s syndrome","volume":"10","author":"Wang","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cyto.2008.10.007_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2008.05.002","article-title":"Effect of infliximab in progressive neuro-Beh\u00e7et\u2019s syndrome","volume":"272","author":"Kikuchi","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.cyto.2008.10.007_bib8","unstructured":"International Study Group for Behcet\u2019s Disease. Criteria for diagnosis of Behcet\u2019s disease. Lancet 1990;335:1078\u20131080."},{"key":"10.1016\/j.cyto.2008.10.007_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0161-5890(02)00210-9","article-title":"The two faces of IL-6 on Th1\/Th2 differentiation","volume":"39","author":"Diehl","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.cyto.2008.10.007_bib10","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1523\/JNEUROSCI.19-13-05236.1999","article-title":"Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor","volume":"19","author":"Van Wagoner","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.cyto.2008.10.007_bib11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/art.1780330506","article-title":"Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement","volume":"33","author":"Hirohata","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2008.10.007_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/03009740600904300","article-title":"Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate","volume":"35","author":"Knudsen","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.cyto.2008.10.007_bib13","first-page":"27","article-title":"Neurotrophin-3, TNF-alpha and IL-6 relations in serum and cerebrospinal fluid of ischemic stroke patients","volume":"64","author":"Pasarica","year":"2005","journal-title":"Roum Arch Microbiol Immunol"},{"key":"10.1016\/j.cyto.2008.10.007_bib14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.47102\/annals-acadmedsg.V33N5p596","article-title":"Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet\u2019s disease","volume":"33","author":"Akdeniz","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.cyto.2008.10.007_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1468-3083.2004.00907.x","article-title":"Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Beh\u00e7et\u2019s disease","volume":"18","author":"Adam","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.cyto.2008.10.007_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","article-title":"Cytokine profile in Beh\u00e7et\u2019s disease patients. Relationship with disease activity","volume":"31","author":"Hamzaoui","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.cyto.2008.10.007_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","article-title":"Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Beh\u00e7et\u2019s disease","volume":"11","author":"Evereklioglu","year":"2002","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cyto.2008.10.007_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0923-1811(95)00439-4","article-title":"Interleukin-6 (IL-6) in patients with Beh\u00e7et\u2019s disease","volume":"11","author":"Yamakawa","year":"1996","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.cyto.2008.10.007_bib19","first-page":"1544","article-title":"Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Beh\u00e7et\u2019s disease. A comparative study with familial Mediterranean fever and healthy subjects","volume":"20","author":"Mege","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2008.10.007_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/02713689208999531","article-title":"Cytokines in human intraocular inflammation","volume":"11","author":"Franks","year":"1992","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.cyto.2008.10.007_bib21","first-page":"321","article-title":"Cytokines in Beh\u00e7et\u2019s disease","volume":"23","author":"Sayinalp","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2008.10.007_bib22","first-page":"904","article-title":"Enhanced interleukin 8 secretion in circulation of patients with Beh\u00e7et\u2019s disease","volume":"22","author":"al-Dalaan","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2008.10.007_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-510X(98)00165-8","article-title":"Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet\u2019s disease","volume":"159","author":"Hirohata","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.cyto.2008.10.007_bib24","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.188.10.1895","article-title":"Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component","volume":"188","author":"Kopf","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2008.10.007_bib25","series-title":"Cellular and molecular immunology","author":"Abbas","year":"2007"},{"key":"10.1016\/j.cyto.2008.10.007_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","article-title":"Cytokines and chemokines in neuro-Beh\u00e7et\u2019s disease compared to multiple sclerosis and other neurological diseases","volume":"145","author":"Saruhan-Direskeneli","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cyto.2008.10.007_bib27","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s004150070049","article-title":"Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases","volume":"247","author":"Celet","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.cyto.2008.10.007_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2249.1998.00620.x","article-title":"Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Beh\u00e7et patients","volume":"113","author":"Ta\u015f\u00e7i","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2008.10.007_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1468-2982.2005.01017.x","article-title":"Headache in Beh\u00e7et\u2019s disease","volume":"26","author":"Aykutlu","year":"2006","journal-title":"Cephalalgia"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466608007667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466608007667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T14:39:47Z","timestamp":1709390387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466608007667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1043466608007667"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2008.10.007","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}